Dr Brett D Miller, | |
1761 Jeffco Blvd, Arnold, MO 63010-2713 | |
(636) 296-1222 | |
(636) 296-1226 |
Full Name | Dr Brett D Miller |
---|---|
Gender | Male |
Speciality | Chiropractic |
Experience | 10 Years |
Location | 1761 Jeffco Blvd, Arnold, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093186223 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
111N00000X | Chiropractor | 2015001189 (Missouri) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Sunset Hills Family Chiropractic Llc | 5395982342 | 5 |
News Archive
Renowned cancer researchers Robert Weinberg, a Founding Member of Whitehead Institute, and Douglas Hanahan, Director of the Swiss Institute for Experimental Cancer Research have updated their seminal review, "Hallmarks of Cancer," which has influenced the study of cancer and the development of therapeutics for more than a decade.
My doctors estimated that I had an 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer, although the risk is different in the case of each woman. Only a fraction of breast cancers result from an inherited gene mutation. Those with a defect in BRCA1 have a 65 percent risk of getting it, on average. Once I knew that this was my reality, I decided to be proactive and to minimize the risk as much I could. I made a decision to have a preventive double mastectomy. I started with the breasts, as my risk of breast cancer is higher than my risk of ovarian cancer, and the surgery is more complex (Angelina Jolie, 5/14).
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it presented positive efficacy and safety data for its doxorubicin targeted conjugate compound, AEZS-108, in ovarian cancer.
Capsaicin, the compound responsible for chilis' heat, is used in creams sold to relieve pain, and recent research shows that in high doses, it kills prostate cancer cells. Now researchers are finding clues that help explain how the substance works. Their conclusions suggest that one day it could come in a new, therapeutic form.
Lexicon Pharmaceuticals, Inc. announced today that an independent, non-profit organization will provide funding to support the Phase 2 development of LX4211 in type 1 diabetes.
› Verified 8 days ago
Provider Name | Sunset Hills Family Chiropractic Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1366782088 PECOS PAC ID: 5395982342 Enrollment ID: O20130510000155 |
News Archive
Renowned cancer researchers Robert Weinberg, a Founding Member of Whitehead Institute, and Douglas Hanahan, Director of the Swiss Institute for Experimental Cancer Research have updated their seminal review, "Hallmarks of Cancer," which has influenced the study of cancer and the development of therapeutics for more than a decade.
My doctors estimated that I had an 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer, although the risk is different in the case of each woman. Only a fraction of breast cancers result from an inherited gene mutation. Those with a defect in BRCA1 have a 65 percent risk of getting it, on average. Once I knew that this was my reality, I decided to be proactive and to minimize the risk as much I could. I made a decision to have a preventive double mastectomy. I started with the breasts, as my risk of breast cancer is higher than my risk of ovarian cancer, and the surgery is more complex (Angelina Jolie, 5/14).
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it presented positive efficacy and safety data for its doxorubicin targeted conjugate compound, AEZS-108, in ovarian cancer.
Capsaicin, the compound responsible for chilis' heat, is used in creams sold to relieve pain, and recent research shows that in high doses, it kills prostate cancer cells. Now researchers are finding clues that help explain how the substance works. Their conclusions suggest that one day it could come in a new, therapeutic form.
Lexicon Pharmaceuticals, Inc. announced today that an independent, non-profit organization will provide funding to support the Phase 2 development of LX4211 in type 1 diabetes.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Brett D Miller, 1761 Jeffco Blvd, Arnold, MO 63010-2713 Ph: (636) 296-1222 | Dr Brett D Miller, 1761 Jeffco Blvd, Arnold, MO 63010-2713 Ph: (636) 296-1222 |
News Archive
Renowned cancer researchers Robert Weinberg, a Founding Member of Whitehead Institute, and Douglas Hanahan, Director of the Swiss Institute for Experimental Cancer Research have updated their seminal review, "Hallmarks of Cancer," which has influenced the study of cancer and the development of therapeutics for more than a decade.
My doctors estimated that I had an 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer, although the risk is different in the case of each woman. Only a fraction of breast cancers result from an inherited gene mutation. Those with a defect in BRCA1 have a 65 percent risk of getting it, on average. Once I knew that this was my reality, I decided to be proactive and to minimize the risk as much I could. I made a decision to have a preventive double mastectomy. I started with the breasts, as my risk of breast cancer is higher than my risk of ovarian cancer, and the surgery is more complex (Angelina Jolie, 5/14).
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it presented positive efficacy and safety data for its doxorubicin targeted conjugate compound, AEZS-108, in ovarian cancer.
Capsaicin, the compound responsible for chilis' heat, is used in creams sold to relieve pain, and recent research shows that in high doses, it kills prostate cancer cells. Now researchers are finding clues that help explain how the substance works. Their conclusions suggest that one day it could come in a new, therapeutic form.
Lexicon Pharmaceuticals, Inc. announced today that an independent, non-profit organization will provide funding to support the Phase 2 development of LX4211 in type 1 diabetes.
› Verified 8 days ago
Dr. Scott D Jones, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2028 Rosedale Ct, Arnold, MO 63010 Phone: 314-544-7961 | |
Upper Level Chiropractic, Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3911 Vogel Road, Arnold, MO 63010 Phone: 636-287-3444 Fax: 636-287-3440 | |
Dr. Thomas Grant Hobbs, DC MD Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 16 Municipal Dr, Suite E, Arnold, MO 63010 Phone: 636-296-1093 Fax: 636-296-5955 | |
Miri Logan, Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 643 Idaho Dr, Arnold, MO 63010 Phone: 314-972-3572 | |
Dr. Catherine Money, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2192 Tenbrook Rd, Arnold, MO 63010 Phone: 636-692-4320 | |
Pamela W Tanner, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 2090 Elm Dr, Ste B, Arnold, MO 63010 Phone: 636-296-4000 Fax: 636-282-8530 |